| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 603-604 |
| Número de páginas | 2 |
| Publicación | Neurology |
| Volumen | 94 |
| N.º | 14 |
| DOI | |
| Estado | Published - abr 7 2020 |
Nota bibliográfica
Funding Information:Supported by the NIH.
Funding Information:
D.C. Park has received investigator-initiated grants from Avid Radiopharmaceuticals, a Division of Eli Lilly and Co. She has also received grant funding from the NIH. E. Abner has received grant funding from the NIH. Go to Neurology.org/N for full disclosures.
Financiación
Supported by the NIH. D.C. Park has received investigator-initiated grants from Avid Radiopharmaceuticals, a Division of Eli Lilly and Co. She has also received grant funding from the NIH. E. Abner has received grant funding from the NIH. Go to Neurology.org/N for full disclosures.
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | |
| National Institutes of Health (NIH) |
ASJC Scopus subject areas
- Clinical Neurology